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One bout of vibration exercise with vascular occlusion activates satellite 
cells 
 Acute skeletal muscle satellite cell (SC) activation is associated with skeletal muscle 
hypertrophy. Although SC quantity has been reported to increase following a single bout of 
resistance exercise, data on muscle fibre type-specific SC quantity and/or activation status 
after single bout of vibration and/or occlusion exercise are presently lacking.  
 
 By determining SCs from muscle biopsies of the M. vastus lateralis using 
immunohistochemistry, we conclude that modification of vibration exercise by superimposing 
occlusion induced activation and differentiation of SC in young men, all of which had not 
been observed with WBV or BFR alone. 
 
Abstract 
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Introduction: We tested the hypothesis that whole body vibration (WBV) is insufficient to expand 
satellite cell (SC) numbers 24 h post exercise, whereas WBV in combination with blood flow 
restriction (BFR) is. Methods: Twenty-five young men were randomly assigned to one of three 
groups: WBV, BFR exercise or WBVBFR. SC numbers were determined from muscle biopsies of the 
vastus lateralis using immunohistochemistry. Results: SC quantity and frequency (+99.38%, P = 
0.012 and +77.1%, P = 0.010, respectively) only increased in the WBVBFR group. Similar results 
were obtained for the quantity and frequency of myogenin+ myonuclei (+139.0%, P < 0.001 and 
+148.4%, P < 0.001, respectively). Conclusion: We conclude that modification of WBV by 
superimposing BFR induced activation and differentiation of SC in young men, all of which had not 
been observed with WBV or BFR alone. These data suggest that WBVBFR might represent a novel 
viable anabolic stimulus. 
 
Key words: satellite cells, hypertrophy, exercise, whole body vibration, blood flow restriction 
Abbreviations: 
BFR, blood flow restriction; CSA, cross-sectional area; DNA, deoxyribonucleic acid; DAPI, 4’,6-
diamidino-2-phenylindole; HGF, hepatocyte growth factor; MND, myonuclear domain; MRF, muscle 
regulatory factor; MyHC, myosin heavy chain isoform; NGS, normal goat serum; NCAM, neural cell 
adhesion molecule; NO, nitric oxide; Pax7, transcription factor paired box protein 7; ROI, region of 
interest; SC, satellite cell; SD, standard deviation; VEGF, vascular endothelial growth factors; WBV, 
whole body vibration; 1RM, one repetition maximum. 
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Whole body vibration (WBV) has long been suggested as an alternative training modality. However, 
despite some evidence that a single bout of WBV can cause a transient potentiation of muscle power, 
it remains inconclusive whether multiple bouts of WBV over several days and weeks can lead to 
sustained neuromuscular adaptations with longer-lasting increases in muscle power and force. In fact, 
some studies found that longer-term WBV (vibration frequency: 25–40 Hz, amplitude: 2.5–3.4 mm) 
can cause gains in knee extensor torque, countermovement jump power, and jumping height in young 
healthy individuals (Delecluse et al. 2003; Torvinen et al. 2003), comparable to those observed after 
resistance exercise, but others have not (Cochrane et al. 2004; Torvinen et al. 2002). 
 
Where it was assessed, the increase in muscle power was paralleled by an increase in muscle mass
 
(Bogaerts et al. 2007) or fat free mass (Roelants et al. 2004). However, these studies were conducted 
with elderly men and untrained women, respectively. For young healthy active individuals, there is no 
convincing evidence that long-term WBV can effectively increase muscle mass or muscle fibre cross-
sectional areas (CSA). Accordingly, it has been argued that muscle hypertrophy is unlikely to occur 
after WBV in young healthy individuals (Pollock et al. 2010). The reason for this lack is that at the 
highest amplitude and frequencies of vibration, the greatest muscle activity is similar to that during 
fast walking (~1.7 m s
−1
; Masumoto et al. 2004) and does not exceed 55% of isometric maximal 
voluntary contraction when typical protocols are applied (Pollock et al. 2010). 
 
Skeletal muscle fibre hypertrophy is defined as an increase in muscle fibre volume, with or without 
the addition of myonuclei. This process is primarily driven by the accretion of myofibrillar proteins, 
which are arranged into sarcomeres that are aligned in parallel (defining fibre CSA) and in series 
(defining fibre length). The cellular mechanisms underlying myofibre hypertrophy include increases 
in translational efficiency and/or translational capacity. Furthermore, myofibre hypertrophy largely 
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depends on transcriptional capacity, which in turn results from increases in myofibre DNA content 
through the addition of myonuclei. Therefore, the number of myonuclei is a critical determinant of 
protein synthesis capacity by supplying the amount of DNA which is necessary to sustain gene 
transcription (Favier et al. 2008). 
 
Within the multinucleated skeletal muscle fibre, each myonucleus regulates gene transcription and 
subsequent protein synthesis over a finite volume of cytoplasm (Cheek, 1985; O’Connor et al. 2007). 
This volume per nucleus, commonly named “myonuclear domain“ (MND), is not a stable quantity as 
demonstrated by the fact that initial myofibre hypertrophy can expand the cytoplasmic volume 
associated with each myonucleus (Petrella et al. 2006). Nevertheless, a ceiling size on the MND has 
been suggested (Petrella et al. 2006) based on the concept that sufficient expansion of the MND 
possibly puts each nucleus under greater strain to supply the necessary gene products, driving a 
demand for the addition of new myonuclei to permit growth beyond the ceiling size (Petrella et al. 
2008). Therefore, the recruitment of additional myonuclei may occur at later times after the initial 
hypertrophic stimulus or once existing MNDs have been maximized by protein accretion in response 
to muscle loading (Petrella et al. 2008). 
 
The addition of myonuclei is facilitated by a pool of normally quiescent satellite cells (SC), which can 
be induced to proliferate, differentiate, and fuse as nuclear contributors to existing myofibres 
supporting growth and regeneration (Petrella et al. 2008). These cells are architecturally positioned 
below the basal lamina of the myofibre and are activated by a number of signals, including local and 
systemic growth factors
 
(Hawke & Garry, 2001) and mechanical load (Tidball, 2005). Thus, 
activation, proliferation and differentiation of SC following exercise set the stage for robust myofibre 
hypertrophy following fusion, and act as markers for the anabolic potency of the training stimulus in 
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terms of hypertrophy (Bellamy et al. 2014). 
 
In this study, we hypothesized that WBV is ineffective in stimulating SC in healthy young active men. 
Given that WBV leads to intensities comparable to those during low-intensity exercise and that low-
intensity exercise performed under blood flow restricted (BFR) (ischaemic) conditions can induce 
hypertrophy (Abe et al. 2006; Ohta et al. 2003; Takarada et al. 2000) we further hypothesized that 
WBV under BFR conditions (WBVBFR) would increase the number of SC to a larger extent 
compared to WBV. To test our hypotheses, three groups of young active men performed either a static 
half-squat standing on a side-alternating vibration plate (WBV group), a static half-squat under BFR 
conditions without vibration (BFR group), or a static half-squat standing on a side-alternating 
vibration plate under BFR conditions (WBVBFR group). Before and 24 h after the stimulus, muscle 
biopsies were taken from the vastus lateralis muscle to analyse the SC response to exercise. 
 
Methods 
Participants 
The study was approved by the ethics committee of the canton Zurich (Switzerland) and was 
conducted in accordance with the Declaration of Helsinki. Twenty-five recreationally active males 
volunteered to participate in this study. Participants were assigned to one of three intervention groups 
(either WBV, BFR or WBVBFR), matched for anthropological constitution (Table 1). They were 
involved in team or individual sports and performed 2-3 exercise sessions per week, of which at least 
one training sessions involved structured resistance exercise. All participants had been engaged in 
these activities on a regular basis for at least one year prior to the study. The resulting number of 
participants was n = 8, n = 9 and n = 8 for the WBV, BFR, and WBVBFR group, respectively. 
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Participants were fully informed about the purposes, benefits and risks associated with this 
intervention and completed a routine health questionnaire before giving written informed consent to 
their participation in this study.  
 
Experimental procedures 
The study consisted of baseline measurements of anthropological variables, a baseline muscle biopsy, 
one acute intervention (consisting of either a static half-squat with WBV, a static half-squat with BFR, 
or a static half-squat with WBVBFR), and a biopsy 24 h after the intervention.  
 
Acute training intervention  
All participants were asked to support a static half-squat position in a flexed knee angle of 135° (180°: 
knees fully extended). The knee angle was consistently checked using a manual goniometer. The feet 
were placed to the width of the pelvis and remained parallel. The WBV group performed the static 
half-squat exercise standing on a Galileo
®
 vibration plate (Novotec, Pforzheim, Germany) oscillating 
at 30 Hz with an amplitude of 2.56 ± 0.42 mm. In the BFR group, tourniquet cuffs (0.09 m width, 076 
m length; VBM, Sulz a.N., Germany) were affixed to the inguinal fold region of the participant's thigh 
and inflated to 200 mmHg (26.7 kPa) while performing squat exercise. Participants in the WBVBFR 
group performed the static half-squat exercise using WBV and BFR. For all groups, one duty cycle 
consisted of 4 min static half-squat and 3 min resting. This duty cycle was repeated three times. In the 
resting period, the cuffs were deflated to 100 mmHg (13.3 kPa) for 1 min and then deflated to 0 
mmHg for the remaining time (BFR and WBVBFR groups only).  
 
Muscle biopsy sampling  
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Two biopsies of the M. vastus lateralis were obtained from the dominant leg after local anesthesia 
with 1 % lidocaine from the middle portion of the dominant vastus lateralis muscle, using a 6-mm 
Bergström needle (Dixons Surgical Instruments, Essex, UK), with suction applied. The first biopsy 
served to generate baseline measures for variables of interest, including muscle fibre type distribution, 
fibre CSA, SC quantity and subsarcolemmal myonuclear number. The first biopsy was obtained 14–
21 d before the training intervention in order to minimize any effects of the biopsy procedure on SC 
counts performed on the second biopsy (Dreyer et al. 2006). The second biopsy was taken 24 h after a 
single bout of WBV, BFR or WBVBFR exercise. All participants were instructed to refrain from 
exercise for 24 h before each biopsy. Biopsies were obtained from the mid-portion of the M. vastus 
lateralis muscle almost 18 cm proximal to the patella, approximating the midline of the quadriceps 
muscle group. The second biopsy was performed at a distance of 1-2 cm proximal or distal (randomly 
assigned) to the baseline biopsy site. Generally 100-150 mg of muscle tissue was obtained from each 
biopsy. 
 
Muscle biopsy analyses 
Transverse consecutive serial sections (8-10 μm) of the embedded muscle biopsy specimen were cut 
at −22 °C using a cryostat (Leica CM 3050 S, Solms, Germany) and were mounted on Fisherbrand 
Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA, USA). The serial cryocut cross-
sections were stained using the myofibrillar adenosintriphosphatase (mATPase) method at pH 4.6 as 
previously described (Mueller et al. 2014). Muscle fibres were classified according to their myosin 
heavy chains (MyHC) isoform into MyHC-1, MyHC-2A and MyHC-2X. For the fibre type specific 
determination of the CSA, MND and SC assignments, a method used for myofibre typing based on 
MyHC isoform immunoreactivity was applied (Kim et al. 2005). Specifically, monoclonal antibodies 
against MyHC specific to human for MyHC-1 (mouse MAb NCL-MHCs, Novacastra Laboratories, 
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Newcastle upon Tyne, UK, 1:100), MyHC-2A (anti-MHC 2a mouse MAb, Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA, USA, 1:80) and for the cell borders (anti-
laminin mouse MAb, Novacastra Laboratories, Newcastle upon Tyne, UK, 1:80) were used. As 
second antibodies, DyLights 488 and 594 [goat anti-mouse IgG (H+L), DyLight 488/594, Pierce 
Antibody Products, Waltham, MA, USA, 1:200] were applied as described by Kim et al.
 
2005. SC 
and differentiation status were identified on consecutive 8 μm thick cross-sections by 
immunohistochemical staining’s for the paired box transcription factor Pax7 (Walker et al. 2012) and 
the muscle regulatory factor (MRF) myogenin (Hanssen et al. 2013). Specifically, sections were fixed 
using a 4% paraformaldehyde solution for 5 min at room temperature followed by 3 times 5 min 
rinses with phosphate buffered saline (PBS) solution. Sections were blocked with 10% normal goat 
serum (NGS) plus 0.5% Triton-X 100 for 45 min. Sections were incubated overnight at 4 °C with 
primary antibodies, mouse anti-Pax7 (Developmental Studies Hybridoma Bank, University of Iowa, 
Iowa City, IA, USA, 1:300) or rabbit anti-myogenin (Santa Cruz Biotechnology, Dallas, TX, USA, 
1:200). Anti-laminin mouse MAb (Novacastra Laboratories, Newcastle upon Tyne, UK, 1:80) was 
applied at 37 °C in the dark for 30 min in order to detect cell borders. Sections were rinsed 3 times for 
5 min each with PBS and blocked with 5% NGS in PBS, followed by 30 min incubation with 
secondary antibodies, DyLight 594 goat anti-rabbit and goat anti-mouse [goat anti-mouse IgG (H+L), 
DyLight 594, Pierce Antibody Products, Waltham, MA, USA, 1:200] and DyLight 488 goat anti-
mouse [goat anti-mouse IgG (H+L), DyLight 488, Pierce Antibody Products, Waltham, MA, USA, 
1:200], at 37 °C in the dark. Sections were rinsed 3 times for 5 min each with PBS and mounted with 
cover slips in mounting medium (ProLong Gold Antifade Reagents with DAPI, Molecular Probes, 
Invitrogen, Carlsbad, CA, USA). 
 
Image analyses 
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For each muscle sample, non-overlapping images were randomly chosen. The staining protocol 
resulted in myonuclei staining blue, MyHC-1 red, MyHC-2A and laminin green, while MyHC-2X 
remained uncoloured (black; Fig. 1.1 a; Fig. 1.2 a). Myofibres positive for MyHC-1 and negative for 
MyHC-2 were classified as type 1, fibres positive for MyHC-2A and negative for MyHC-1 were 
classified as type 2A, and fibres negative for both MyHC-1 and MyHC-2A were classified as type 2X. 
SC (Pax7+ cells) had to be localized to the membrane (laminin stained green), stained red and co-
located with DAPI (blue; Fig. 1.1 b,c,d). The number of SC divided by the number of muscle fibres 
was categorized as SC quantity. The number of SC divided by the total number of subsarcolemmal 
myonuclei was categorized as SC frequency. Likewise, to assure myogenin fibre type specificity, the 
MyHC staining resulted the same as described above (Fig. 1.2 a). Myogenin positive myonuclei 
(myogenin+ myonuclei) were localized to the membrane (laminin stained green) of a muscle fibre and 
identified as any nuclei stained red co-located with DAPI (blue; Fig. 1.2 b,c,d). The number of 
myogenin+ cells divided by the number of muscle fibres was categorized as quantity of myogenin+ 
myonuclei. The number of myogenin+ cells divided by the total number of subsarcolemmal 
myonuclei was categorized as frequency of myogenin+ myonuclei. Results are shown for both MyHC 
isoforms taken together (i.e. all fibre type), MyHC-1 and MyHC-2. Muscle fibre type-specific 
association of the SC was conducted by assigning the randomly chosen area to the consecutive muscle 
cross-sections, immunostained to identify fibre types. As the correlation coefficient for counting SC 
continues to increase with increasing numbers of fibres in the analysis (Mackey et al. 2009), we 
analysed at least a total of 50 MyHC-1 and 75 MyHC-2 muscle fibres to guarantee reliability. Fibre 
CSA were calculated by fully encircling the laminin borders of the MyHC-stained cells of at least 50 
fibres per MyHC isoform and computing the area within the borders (McCall et al. 1998). Within 
each image, every fibre cross-sectional area with its corresponding number of myonuclei per fibre was 
used to calculate the MND, which was defined as the ratio of each fibre cross-sectional area divided 
by the number of myonuclei per fibre, i.e. the area controlled by a single nucleus. We used the NIH 
Image J Software (version 1.44o, National Institutes of Health, Bethesda, MD, USA) and Photoshop 
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Pro CS6 (Adobe Systems Incorporated, San Jose, CA, USA) for all fibre analyses. Fibre circularity 
was calculated using the formula (4π x CSA)/(perimeter)2 and only fibres with a circularity higher 
than 0.65 were considered for analysis (perfect circle = 1.0). Due to insufficient number of MyHC-2X 
fibres, analyses of the variables were therefore confined to MyHC-1 and MyHC-2, with MyHC-2 
variables being a weighted average based on the relative distributions of MyHC-2A and MyHC-2X 
myofibres. The same investigator carried out all analyses manually.  
 
A total of 4048 (baseline-training) and 3862 (acute-training) fibres from 25 participants were analysed 
for SC quantity and SC frequency. A mean of 162 ± 5 fibres and an average of 11 ± 0.5 SC were 
analysed per biopsy sample. An average of 71 ± 13 fibres were analysed for the determination of 
CSA, myonuclear number and MND per biopsy sample. On average, 790 ± 260 muscle fibres per 
participant (baseline biopsy) were classified according to their MyHC isoform into MyHC-1 (389 ± 
121), MyHC-2A (328 ± 158) and MyHC-2X (74 ± 114). The results for each variable are reported as 
general group means as well as mean per fibre type for each group. 
 
Body composition  
A densitometer (Lunar iDXA™, GE Healthcare, Madison, WI, USA) was used for the determination 
of thigh lean mass. The delineation in region of interest (ROI) for the legs was done manually using 
the integrated software (encore, GE Healthcare, Madison, WI, USA; version 11.40.004) as follows: 
ROI’s upper boundary = horizontal line just below the ischium; ROI’s lower boundary = horizontal 
line below the feet; ROI’s lateral boundaries = outer leg cuts. 
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Statistical analysis 
Data are presented as mean values ± standard deviations (SD). Normality of data was visually 
ascertained by Q–Q-plots. Baseline values between the training groups were analysed with a one-way 
analysis of variance. For the detection of significant differences between groups over time, a 
univariate general linear model was applied. For this analysis, the differences acute–baseline (%) of 
each variable was compared between the groups. Significant differences within groups from baseline- 
to acute-intervention were displayed by parameter estimates. This analysis tested the null hypothesis 
that Δ parameter was 0. If Δ parameter had a P-value lower than the level of significance, the null 
hypothesis was rejected meaning that Δ parameter was significantly different from 0. The level of 
significance was set at P < 0.05. All statistical analyses were performed using the software SPSS 
Statistics 20.0 (SPSS, Chicago, IL, USA). 
 
Results 
Muscle fibre cross-sectional area, myonuclear number and myonuclear domain 
CSA did not differ between groups at baseline (Table 2). Likewise, the number of subsarcolemmal 
myonuclei was not different at baseline either (Table 2). Accordingly, no differences in the MND 
were observed at baseline between groups (Table 2).  
 
Muscle fibre distribution 
At baseline, MyHC-1 proportion was significantly higher in the BFR-group compared to the WBV-
group (P = 0.035, Table 3). No further statistical differences were present for MyHC fibre distribution 
between intervention groups. 
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Baseline SC quantity and frequency 
The SC quantity and frequency per all myofibre type was not different at baseline between groups 
(Fig. 2A, D). In addition, when expressed per fibre type, the SC quantity and frequency did not differ 
at baseline between groups, either (for SC quantity, Fig. 2B, E; for SC frequency, Fig. 2C, F). 
 
Acute increases in SC quantity and frequency  
The SC quantity per all myofibre remained unchanged in the WBV and BFR group (Fig. 2A), while it 
increased in the WBVBFR group (P = 0.002; Fig. 2A). Furthermore, when expressed per fibre type, 
SC quantity increased in the WBVBFR group only [P = 0.016 and P = 0.002, for MyHC-1 (Fig. 2B) 
and MyHC-2 (Fig. 2C), respectively]. There was no corresponding between-group difference in 
MyHC-fibre type-specific SC quantity (Fig. 2A). The SC frequency per all myofibre did not change in 
the WBV and BFR group (Fig. 2D). SC frequency per all myofibre increased in the WBVBFR group 
(P = 0.010; Fig. 2D). Fibre type specific SC frequency did not increase in any group (Fig. 2E, F). 
 
Baseline quantity and frequency of myogenin+ myonuclei  
The quantity and frequency of myogenin+ myonuclei per all myofibre was not different at baseline 
between groups (Fig. 3A, D). In addition, when expressed per fibre type, the quantity and frequency 
of myogenin+ myonuclei did not differ at baseline between groups, neither (Fig. 3B, C, E, F). 
 
Acute increases in quantity and frequency of myogenin+ myonuclei  
  
 
This article is protected by copyright. All rights reserved. 
 
14 
The quantity of myogenin+ myonuclei per all fibre type remained unchanged in the WBV and BFR 
group (Fig. 3A). Therefore, the quantity of myogenin+ myonuclei per all fibre type did not change in 
these groups. By contrast, the quantity of myogenin+ myonuclei per all fibre type increased in the 
WBVBFR group (P < 0.001; Fig 3A). The quantity of myogenin+ myonuclei per all fibre type was 
different between groups (P = 0.011 for WBVBFR vs. WBV and P = 0.006 for WBVBFR vs. BFR; 
Fig. 3A). Furthermore, when expressed per fibre type, the quantity of myogenin+ myonuclei increased 
in the WBVBFR group only [P < 0.001 and P < 0.001, for MyHC-1 (Fig. 3B) and MyHC-2 (Fig. 3C), 
respectively]. The frequency of myogenin+ myonuclei per all fibre type in the WBV and BFR group 
did not change (Fig 3D). The frequency of myogenin+ myonuclei per all fibre type increased in the 
WBVBFR group only (P < 0.001; Fig. 3D). The increase in quantity of myogenin+ myonuclei per all 
fibre type was different between groups (P = 0.048 for WBVBFR vs. WBV; Fig. 3D). In the 
WBVBFR and BFR group, the frequency of myogenin+ myonuclei increased for MyHC-1 and 
MyHC-2 (MyHC-1: P = 0.013 and P = 0.012 for WBVBFR and BFR, respectively; Fig 3E; MyHC-
2: P = 0.012 and P = 0.039 for WBVBFR and BFR, respectively, Fig. 3F). No changes were 
observed for the WBV group (Fig. 3E, F). 
 
Discussion 
This study provided evidence that a single bout of WBV exercise did affect neither SC quantity nor 
the number of myogenin+ myonuclei 24 h post exercise in recreationally trained young men. 
Similarly, BFR exercise did not elicit either activation or differentiation of SC. In contrast, SC 
quantity was increased 24 h after a single bout of WBVBFR exercise and a concomitant increase in 
the number of myogenin+ myonuclei occurred. 
 
The MND, which was below the proposed ceiling size of approximately 2000 µm
2
 (Petrella et al. 
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2006) was not different between groups at baseline. Consequently, it is unlikely that the facilitated 
increase in SC quantity, which occurred exclusively in the WBVBFR group, was attributed to 
baseline differences in the potential to expand the MND. Notably, no between-group differences in 
SC quantity were observed, despite between-group differences in muscle fibre type distribution. In 
fact, the proportion of MyHC-1 fibres was higher for BFR than WBV at baseline, yet SC quantity was 
similar. Our data do not support the notion that MyHC-1 fibres have more SC than MyHC-2 fibres but 
instead lend further credence to the results of Kadi et al.
 
2006, which concluded that SC distribution 
in human vastus lateralis is not dependent on fibre type composition.  
 
It can also be excluded beyond reasonable doubt that between-group differences in the myogenic 
potential dictated the observed between-group differences in SC proliferation and differentiation after 
acute exercise in this study. As shown by Petrella et al.
 
2008, high responders to resistance exercise-
induced myofibre hypertrophy exhibited a significantly larger baseline SC quantity than moderate or 
low responders, as evidenced by the higher number of positive neural cell adhesion molecule cells 
(NCAM+) per fibre as well as the number of NCAM+ cells relative to total subsarcolemmal 
myonuclear number in this group. Thus, one’s myogenic potential might at least partially be 
predetermined by the availability of SC before training (Petrella et al. 2006). Given that no difference 
in SC quantity was observed between groups at baseline, all three groups started with the same 
myogenic potential in terms of having the same availability of SC at baseline. The absence of 
between-group differences in baseline SC quantity in this study supports the notion that the SC 
quantity in recreationally trained muscle is tightly regulated and thus, held fairly constant in steady-
state conditions (Dhawan & Rando, 2005). Similar to SC quantity, the number of differentiating SC 
(myogenin+ SC) was equal for all three groups at baseline, too. As no group differences were found at 
baseline for this marker of differentiation, it is unlikely that group differences in cell cycle 
progression could explain the group difference in the response to acute exercise. 
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This is the first study to show that stand-alone, neither WBV nor BFR were sufficient to induce 
proliferation and differentiation of SC 24 h post intervention, while the simultaneous combination of 
the two stimuli (WBVBFR) was. A substantial increase in SC quantity and a concomitant rise in the 
number of myogenin+ myonuclei occurred 24 h after a single bout of WBVBFR exercise in a non 
muscle fibre type-specific manner. Several studies have shown that SC numbers are elevated as soon 
as 24 h after exercise, especially for resistance exercise-type regimen involving lengthening muscle 
actions (Cermak et al. 2013; O’Reilly et al. 2008). In particular, and similar to the results obtained for 
WBVBFR, it was shown that resistance exercise induced a significant increase in the number of 
Pax7+ cells 24 h post exercise in young men (Walker et al. 2012). The effect of WBVBFR on the 
number of Pax7+ cells (+99.5%) was similar to the one observed for resistance exercise (+147.6%). 
Our finding is intriguing, since the development of a low-mechanical strain intervention to increase 
muscle function has considerable clinical significance. There are many conditions where traditional 
high force paradigms for muscle adaptation cannot be used. For example, in injured and postsurgical 
patients with compromised musculotendinous integrity, high force loading of a joint or muscle is 
frequently contraindicated. In this regard, WBVBFR could represent an interesting alternative. 
 
As expected, the WBV group did not show any elevations in SC quantity and frequency, possible 
reason being that the applied vibration mode (vibration type, amplitude and frequency) did not elicit 
enough metabolic fatigue and/or mechanical strain for activating anabolic-signalling pathways in 
young, healthy trained men. As demonstrated by Wahl et al.
 
2014, high-intensity training (i.e. 4x4 
min or 4x30 s high-intensity endurance exercise) stimulated a transient increase in circulating levels 
of vascular endothelial growth factors (VEGF) and hepatocyte growth factors (HGF), whereas high-
volume training (i.e. 120 min at 55% peak power output) had no influence on VEGF and HGF. This 
points towards an intensity dependence in cell cycle transition of differentiated SCs, which was not 
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accomplished by WBV alone. Despite that WBV has been reported to increase electromyographic 
activity (Perchthaler et al. 2013; Pollock et al. 2012; Yasuda et al. 2008), motor unit recruitment 
(Pollock et al. 2012; Yasuda et al. 2008; Manini et al. 2011),  static half-squat on a vibrating platform 
did not induce up regulation in the numbers of myogenin+ myonuclei and therefore do not promote 
myotube fusion in young, healthy trained men. Equally, 24 h after a single bout of BFR exercise, 
neither SC quantity nor the number of myogenin+ myonuclei were changed. In contrast to the results 
of Wernbom et al.
 
2013, which measured an about three- to fourfold elevation of differentiated SC, 
our data showed no elevated number of myogenin+ myonuclei after a single bout of BFR. Thus, only 
a single bout of BFR exercise combined with dynamic resistance exercise could cause elevations in 
SC numbers. It may be concluded, that just standing in the half-squat position with BFR, did no elicit 
activation and differentiation of SC.  
 
In conclusion, this study has provided evidence that modification of WBV by superimposing vascular 
occlusion induced activation and differentiation of SC, all of which had not been observed with WBV 
or BFR alone. The increase in SC activation and differentiation status was not fibre-type specific, 
indicating that superimposing WBV with BFR may change motor unit recruitment pattern and fibre 
activation, thereby providing the basis for a new anabolic treatment in recreationally young trained 
men. Based on these findings, we recommend that trained young men who aim at further improving 
their anabolic potential should also consider WBVBFR. Finally, WBVBFR could also represent an 
interesting anabolic alternative to high force exercise in patients and/or elderly individuals. 
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Tables 
Table 1 Physical characteristics 
 WBV BFR WBVBFR 
Age (years) 26.8 ± 1.2 27.7 ± 4.6 26.6 ± 4.0 
Height (cm) 176.6 ± 5.9 180.9 ± 9.1 183.1 ± 6.9 
Body mass (kg) 78.9 ± 14.0 83.2 ± 10.0 79.2 ± 10.0 
Leg lean mass (kg) 20.9 ± 3.5 22.1 ± 2.5 22.8 ± 2.5 
Values are means ± SD for three groups of young active men performing either a static half-squat standing on a side-
alternating vibration plate (WBV: n = 8), a static half-squat under blood flow restriction conditions without vibration (BFR: 
n = 9), or a static half-squat standing on a side-alternating vibration plate under BFR conditions (WBVBFR: n = 8). 
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Table 2 Muscle fibre characteristics and myonuclear domain. 
  Group MyHC Baseline Acute 
     
Muscle fibre CSA [𝜇m2] WBV All 4970.9 ± 962.4 4986.8 ± 1173.1 
  MyHC-1 4818.6 ± 1048.5 4736.3 ± 1128.2 
  MyHC-2 5123.2 ± 1121.9 5237.3 ± 1328.8 
 BFR All 5777.2 ± 1467.7 6004.6 ± 2021.8 
  MyHC-1 5461.5± 1372.9 5500.7 ± 2031.9 
  MyHC-2 6092.9 ± 1769.0 6508.5 ± 2149.4 
 WBVBFR All 5041.9 ± 529.1 5268.9 ± 792.5 
  MyHC-1 4549.6 ± 493.8 4771.5 ± 940.1 
  MyHC-2 6092.9 ± 1769.0 6508.5 ± 2149.4 
Subsarcolemmal myonuclei/Fibre WBV All 3.2 ± 0.4 3.3 ± 0.4 
  MyHC-1 3.4 ± 0.5 3.5 ± 0.5 
  MyHC-2 3.0 ± 0.4 3.1 ± 0.4 
 BFR All 3.4 ± 0.4 3.5 ±0.5 
  MyHC-1 3.4 ± 0.3 3.7 ± 0.5 
  MyHC-2 3.2 ± 0.5 3.3 ± 0.6 
 WBVBFR All 3.3 ± 0.4 3.4 ± 0.3 
  MyHC-1 3.4 ± 0.4 3.6 ± 0.4 
  MyHC-2 3.1 ± 0.4 3.2 ± 0.2 
MND [𝜇m2] WBV All 1772.6 ± 524.4 1664.3 ± 347.8 
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  MyHC-1 1602.1 ± 455.4 1434.6 ± 336.5 
  MyHC-2 1943.0 ± 632.1 1893.9 ± 414 .7 
 BFR All 2004.9 ± 573.8 1974.6 ± 638.1 
  MyHC-1 1784.8 ± 517.6 1710.8 ± 609.3 
  MyHC-2 2224.9 ± 713.9 2238.4 ± 686.9 
 WBVBFR All 1821.9 ± 279.3 1845.9 ± 474.4 
  MyHC-1 1553.9 ± 271.5 1517.9 ± 414.5 
  MyHC-2 2089.9 ± 322.1 2173.9 ± 605.3 
Mean values of cross-sectional area (CSA), subsarcolemmal myonuclei per fibre and myonuclear domain (MND) for all 
myosin heavy chains (MyHC) isoforms MyHC-1 and MyHC-2, before (baseline) and 24 h after (acute) the exercise 
intervention for the three groups of young active men performing either a static half-squat standing on a side-alternating 
vibration plate (WBV: n = 8), a static half-squat under blood flow restriction conditions without vibration (BFR: n = 9), or a 
static half-squat standing on a side-alternating vibration plate under BFR conditions (WBVBFR n = 8). Values are means ± 
SD.  
Table 3 Muscle fibre type distribution 
 WBV BFR WBVBFR 
    
MyHC-1 [%] 42.8 ± 11.2 55.3 ± 8.8 * 53.7 ± 7.8 
MyHC-2A [%] 43.2 ± 12.8 39.9 ± 9.3 39.2 ± 8.3 
MyHC-2X [%] 14.0 ± 18.3 4..8 ± 3.6 7.1 ± 5.8 
Myosin heavy chains (MyHC) isoform distribution of the three groups of young active men performing either a static half-
squat standing on a side-alternating vibration plate (WBV: n = 8), a static half-squat under blood flow restriction conditions 
without vibration (BFR: n = 9), or a static half-squat standing on a side-alternating vibration plate under BFR conditions 
(WBVBFR: n = 8). Values are means ± SD, * P < 0.05, significant differences relative to WBV group. 
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Captions  
Figure 1.1) Representation of fibre type-specific analyses of skeletal muscle satellite cell (SC) quantity for the 
WBV group (A), BFR group (B) and WBVBFR (C) group, respectively.  
a) Representative image of myosin heavy chains (MyHC) isoform. MyHC-1 (red), MyHC-2A (green), MyCH-
2X (black), subsarcolemmal myonuclei (blue) and cell borders (green), b) Higher magnification of selected area 
(white box), co-localization of SC (red) and subsarcolemmal myonuclei (blue) with cell border lines (green), c) 
Co-localization of SC (red) and subsarcolemmal myonuclei (blue), d) SC (red), Scale bar represents 100 𝜇m (a). 
Scale bar represents 20 𝜇m (b,c,d). 
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Figure 1.2) Representation of fibre type-specific analyses of skeletal muscle myogenin+ myonuclei quantity for 
the WBV group (A), BFR group (B) and WBVBFR (C) group, respectively. 
a) Representative image of myosin heavy chains (MyHC) isoform. MyHC-1 (red), MyHC-2A (green), MyCH-
2X (black), subsarcolemmal myonuclei (blue) and cell borders (green), b) Higher magnification of selected area 
(white box), co-localization of SC (red) and subsarcolemmal myonuclei (blue) with cell border lines (green), c) 
Co-localization of myogenin+ myonuclei (red) and subsarcolemmal myonuclei (blue), d) Myogenin+ myonuclei 
(red). Scale bar represents 100 𝜇m (a). Scale bar represents 20 𝜇m (b,c,d). 
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Figure 2: A) Total (i.e. all fibre type) satellite cell (SC) quantity from the vastus lateralis muscle of young men 
before (baseline: white bars) and 24 h after (acute: black bars) performing either a static half-squat standing on a 
Galileo side-alternating vibration plate (WBV: n = 8), a static half-squat under blood flow restriction (BFR) 
conditions without vibration (BFR: n = 9), or a static half-squat standing on a Galileo side-alternating vibration 
plate under BFR (WBVBFR: n = 8), B) SC quantity for MyHC-1, C) SC quantity for MyHC-2, d) Total (i.e. all 
fibre type) satellite cell (SC) frequency, e) SC frequency for MyHC-1, f) SC frequency for MyHC-2. Bars and 
error bars represent mean values and SD. *P < 0.01, significant differences within group baseline vs. acute. 
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Figure 3: A) Total (i.e. all fibre type) quantity of myogenin+ myonuclei from the vastus lateralis muscle of 
young men before (baseline: white bars) and 24 h after (acute: black bars) performing either a static half-squat 
standing on a Galileo side-alternating vibration plate (WBV: n = 8), a static half-squat under blood flow 
restriction (BFR) conditions without vibration (BFR: n = 9), or a static half-squat standing on a Galileo side-
alternating vibration plate under BFR (WBVBFR: n = 8). B) Myogenin+ myonuclei quantity for MyHC-1, C) 
Myogenin+ myonuclei quantity for MyHC-2, D) Total (i.e. all fibre type) frequency of myogenin+ myonuclei 
E) Myogenin+ myonuclei frequency for MyHC-1, F) Myogenin+ myonuclei frequency for MyHC-2. Bars and 
error bars represent mean values and SD. * P <0.05, *** P <0.001, significant differences within group baseline 
vs. acute. # P <0.05, ## P < 0.01, significant differences between groups baseline vs. acute. 
 
